ITGAM and neoplasm: The comparison of the two tumor subtypes showed significant differences in the percentage of CD335+/CD11b+ NK cells in PBMCs treated with EVs from HS578T cells, although these were lost when PBMCs were treated with EVs derived from 3D model.